Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Biliary Tract Diseases

  Free Subscription


Articles published in J Pediatr

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    September 2022
  1. HOSHINO E, Moriwaki K, Morimoto K, Sakai K, et al
    Cost-effectiveness analysis of universal screening for biliary atresia in Japan.
    J Pediatr. 2022 Sep 27. pii: S0022-3476(22)00850.
    PubMed     Abstract available


  2. OSBORN JB
    50 Years Ago in TheJournalofPediatrics: Understanding Progressive Cholestatic Liver Disease.
    J Pediatr. 2022;248:58.
    PubMed    


    July 2022
  3. PANDURANGI S
    50 Years Ago in TheJournalofPediatrics: Medical Therapies for Pediatric Cholestasis.
    J Pediatr. 2022;246:198.
    PubMed    


    June 2022
  4. SALVI PS, Fawaz R, Cowles RA
    Comparing Serum Matrix Metalloproteinase-7 in Parenteral Nutrition-Associated Liver Disease and Biliary Atresia.
    J Pediatr. 2022 Jun 14. pii: S0022-3476(22)00547.
    PubMed     Abstract available


    May 2022
  5. CHU C, Kohli R
    Nature or Nurture in the pathogenesis of biliary atresia?
    J Pediatr. 2022 May 2. pii: S0022-3476(22)00404.
    PubMed    


    April 2022
  6. CHEN X, Yi B
    Triple Gallbladder.
    J Pediatr. 2022 Apr 12. pii: S0022-3476(22)00316.
    PubMed    


    March 2022
  7. CAVALLO L, Kovar EM, Aqul A, McLoughlin L, et al
    The Epidemiology of Biliary Atresia: Exploring the Role of Developmental Factors on Birth Prevalence.
    J Pediatr. 2022 Mar 29. pii: S0022-3476(22)00288.
    PubMed     Abstract available


    January 2022
  8. SAMYN M, Hensel K, Hadzic N, Mieli-Vergani G, et al
    Reply.
    J Pediatr. 2022;240:317-318.
    PubMed    


    September 2021
  9. AMELIE S, Malte S, Tobias C, Britta S, et al
    KIF12 Variants and Disturbed Hepatocyte Polarity in Children With a Phenotypic Spectrum of Cholestatic Liver Disease.
    J Pediatr. 2021 Sep 20. pii: S0022-3476(21)00893.
    PubMed    


  10. BOLIA R
    Does early diagnosis and management improve liver-related outcomes in children with inflammatory bowel disease and sclerosing cholangitis ?
    J Pediatr. 2021 Sep 13. pii: S0022-3476(21)00885.
    PubMed    


  11. ALI F, Mouzaki M
    50 Years Ago in TheJournalofPediatrics: MCTs: Are They what We want Them to Be?
    J Pediatr. 2021;236:94.
    PubMed    


    August 2021
  12. KHAYAT A, Vitola B
    Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Non-Alcoholic Fatty Liver Disease.
    J Pediatr. 2021 Aug 26. pii: S0022-3476(21)00826.
    PubMed     Abstract available


    July 2021
  13. HENSEL KO, Kyrana E, Hadzic N, Mann J, et al
    Sclerosing Cholangitis in Pediatric Inflammatory Bowel Disease - Early Diagnosis and Management Affect Clinical Outcome.
    J Pediatr. 2021 Jul 22. pii: S0022-3476(21)00739.
    PubMed     Abstract available


    April 2021
  14. AL-HUSSAINI A, Lone K, Bashir MS, Alrashidi S, et al
    ATP8B1, ABCB11, and ABCB4 Genes Defects: Novel Mutations associated with cholestasis with Different phenotypes and Outcomes.
    J Pediatr. 2021 Apr 26. pii: S0022-3476(21)00391.
    PubMed     Abstract available


    February 2021
  15. PORTA G, de Carvalho E, Santos JL, Gama J, et al
    Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
    J Pediatr. 2021;229:95-101.
    PubMed     Abstract available


  16. LUONG R, Feinstein JA, Ma M, Ebel NH, et al
    Outcomes in Patients with Alagille Syndrome and Complex Pulmonary Artery Disease.
    J Pediatr. 2021;229:86-94.
    PubMed     Abstract available


    October 2020
  17. GURA KM, Premkumar MH, Calkins KL, Puder M, et al
    Fish Oil Emulsion Reduces Liver Injury and Liver transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.
    J Pediatr. 2020 Oct 7. pii: S0022-3476(20)31260.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Biliary Tract Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: